[Correction of apathetic-abulic manifestations of schizophrenia with cholinotropic drugs].
The authors describe the results of the treatment of 30 patients suffering from schizophrenia with the well-defined apatho-abulic manifestations. The patients received anticholin-esterase agents (galanthamine and deoxypeganin) combined with the M-cholinolytic drug benactyzine. The treatment lasted 3 to 4 weeks. Satisfactory compensation for the deficiency manifestations was attained in 18 patients (60%). The therapeutic dynamics appeared the best in patients with predominant anergic disorders accompanied by well-defined impoverishment of motor functions. The presence of roductive psychotic disorders in the syndromal structure noticeably decreased the treatment efficacy. The deranged capacity for behavioral initiation classified by the authors with the fundamental deficiency manifestations turned out most refractory to the treatment. The polymediator model of the schizophrenic defect is reviewed, according to which the deficiency manifestations represent adaptive stability states with emergence to a lower energy level. In such a case the neuronal populations with different mediator modality become deactivated. On the one hand, this gives rise to a decrease of psychotic productive disorders, on the other one, to the occurrence of the negative manifestations.
Vovin
R Ia
RIa
Fakturovich
A Ia
AIa
Golenkov
A V
AV
Lukin
V O
VO
D000328:Adult; D000368:Aged; D001535:Benactyzine / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D004644:Emotions / Q000187:drug effects*; D005260:Female; D005702:Galantamine / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology
D005702:Galantamine; D001535:Benactyzine
Korrektsiia apatoabulicheskikh proiavleniĭ protsessual'nogo defekta kholinotropnymi preparatami.